Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
2021
Background. Anti-PD1/PDL1 immune checkpoint inhibitors (ICIs) showed promising results in breast cancer, and exploration of additional actionable immune checkpoints is ongoing. Inflammatory breast ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
86
References
3
Citations
NaN
KQI